Israel
has successfully tested the new missile defense system David Sling's (Stunner),
which can intercept targets with a longer range than those downed by Iron
Dome in the recent Israel- Gaza conflict, the Defense Ministry said Sunday,
November 25, 2012. A Stunner missile launched by the David's Sling system
" intercepts (the) target in (its) inaugural flight," the ministry
said in a statement.
|
By
conducting the successful interception test, "the Israel Missile
Defense Organization and the U.S. Missile Defense Agency completed the
first phase of the development of the David's Sling Weapon System (DSWS),"
it added.
"This test included for the first time a successful interception
by the Stunner Missile of the DSWS. The test was conducted by Rafael Advanced
Defense Systems at a test range in the southern part of Israel,"
the statement said.
Defense Minister Ehud Barak congratulated those involved in the test,
adding that David's Sling would form a significant layer in Israel's multi-layered
missile defense program.
David's Sling is a missile defense system currently under development
by Rafael in Israel and Raytheon in the U.S. and is designed to fill the
gap between Iron Dome's short-range protection and the Arrow 2 long-range
ballistic missile defense program. It is also capable of acting as a back-up
to the Arrow 2, by intercepting incoming threats that manage to slip through
the Arrow's defenses, according to Israeli media reports.
The David's Sling weapon system is composed of a battle management &
command array, as well as an interceptor array. The multi-mission radar
is used for the detection and tracking of threats. The weapon control
system (WCS) is a battle management & weapon control system that enables
optimal, real-time mission planning against a large number of simultaneous
threats. The WCS is also the system's interface to senior command levels,
air control units, as well as to other sensors and defense systems.
The reports quoted a source in Israel's defense industries as saying that
David's Sling was originally scheduled for live trials in 2013, and that
this was brought forward "given the general sense of urgency."
|